Jonathan Israel

Jonathan’s day-to-day practice includes patent prosecution at the European Patent Office (EPO) across a variety of technologies within the life sciences. Jonathan also has experience in defensive and offensive oppositions before the EPO’s Opposition Divisions and Boards of Appeal, as well as preparing invalidity opinions and freedom to operate (FTOs). Prior to joining Mathys & Squire, Jonathan worked at the Technology Transfer Office of Imperial College London, managing a large patent portfolio arising from the commercialisation of university inventions.

Jonathan’s technical expertise includes subject matter relating to mRNA vaccines, including COVID vaccines; antibody and gene therapies; molecular diagnostics; and microbiome therapeutics.

Jonathan is a European Patent Attorney and Chartered UK Patent Attorney. He has also successfully completed a PGCert in Intellectual Property Law with distinction at Queen Mary, University of London.

Jonathan holds an Intellectual Property Litigation Certificate, having successfully completed a basic litigation skills course.

Jonathan has a master’s degree in immunology from Imperial College London. His research project was concerned with the role of the IL-33/ST2 axis in the pathogenesis of idiopathic pulmonary fibrosis. Jonathan previously graduated with a first class bachelor’s degree from University College London, his studies covering a broad range of topics within the life sciences.

Jonathan is a fellow of the Chartered Institute of Patent Attorneys (CIPA) and member of the Institute of Professional Representatives before the European Patent Office (epi).